These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36575438)

  • 1. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
    Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
    BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Wang Y; Xie BH; Lin WH; Huang YH; Ni JY; Hu J; Cui W; Zhou J; Shen L; Xu LF; Lian F; Li HP
    Oncogene; 2019 Jun; 38(25):4948-4961. PubMed ID: 30842588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.
    Zhang H; Zheng Z; Zhang R; Yan Y; Peng Y; Ye H; Lin L; Xu J; Li W; Huang P
    Cell Death Dis; 2021 Jul; 12(8):731. PubMed ID: 34301921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
    Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis.
    Deng L; Yang H; Tang J; Lin Z; Yin A; Gao Y; Wang X; Jiang R; Sun B
    J Exp Clin Cancer Res; 2015 Oct; 34():128. PubMed ID: 26503703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma.
    Qian YY; Liu ZS; Yan HJ; Yuan YF; Levenson AS; Li K
    Biomed Pharmacother; 2018 May; 101():852-859. PubMed ID: 29635894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
    Bian W; Zhang H; Tang M; Zhang S; Wang L; Liu L; Wang W
    Cell Physiol Biochem; 2018; 51(5):2065-2072. PubMed ID: 30522116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of SMYD3 by hepatitis B virus X gene in HepG2 cells].
    Yang L; Ren J; He J; Chen LB
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):297-300. PubMed ID: 19403031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma.
    Fei X; Ma Y; Liu X; Meng Z
    Tohoku J Exp Med; 2017 Nov; 243(3):219-226. PubMed ID: 29187705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation.
    Hayashi M; Deng L; Chen M; Gan X; Shinozaki K; Shoji I; Hotta H
    Microbiol Immunol; 2016 Jan; 60(1):17-25. PubMed ID: 26616333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells.
    Yoo YG; Na TY; Seo HW; Seong JK; Park CK; Shin YK; Lee MO
    Oncogene; 2008 May; 27(24):3405-13. PubMed ID: 18264140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.
    Chen LB; Xu JY; Yang Z; Wang GB
    World J Gastroenterol; 2007 Nov; 13(43):5718-24. PubMed ID: 17963297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis.
    Yin X; Teng X; Ma T; Yang T; Zhang J; Huo M; Liu W; Yang Y; Yuan B; Yu H; Huang W; Wang Y
    Cell Death Differ; 2022 Nov; 29(11):2203-2217. PubMed ID: 35534547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
    Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
    Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.
    Deng L; Tang J; Yang H; Cheng C; Lu S; Jiang R; Sun B
    Oncogene; 2017 Jul; 36(28):3976-3985. PubMed ID: 28288133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THAP3 recruits SMYD3 to OXPHOS genes and epigenetically promotes mitochondrial respiration in hepatocellular carcinoma.
    Wang ZH; Wang J; Liu F; Sun S; Zheng Q; Hu X; Yin Z; Xie C; Wang H; Wang T; Zhang S; Wang YP
    FEBS Lett; 2024 Jun; 598(12):1513-1531. PubMed ID: 38664231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of MTA2-mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK-MMP7 axis.
    Hu HM; Lee HL; Liu CJ; Hsieh YH; Chen YS; Hsueh KC
    Environ Toxicol; 2024 Apr; 39(4):1897-1908. PubMed ID: 38050825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.